Acorah Software Products - Accounts Production 19.3.550 false true 31 December 2024 1 January 2024 false 1 January 2025 31 December 2025 31 December 2025 14024267 Dr Andrew Saich Mr Julian Bryson Mr Rupert Haynes Mr Christopher Mills iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14024267 2024-12-31 14024267 2025-12-31 14024267 2025-01-01 2025-12-31 14024267 frs-core:CurrentFinancialInstruments 2025-12-31 14024267 frs-core:Non-currentFinancialInstruments 2025-12-31 14024267 frs-core:ComputerEquipment 2025-12-31 14024267 frs-core:ComputerEquipment 2025-01-01 2025-12-31 14024267 frs-core:ComputerEquipment 2024-12-31 14024267 frs-core:SharePremium 2025-12-31 14024267 frs-core:ShareCapital 2025-12-31 14024267 frs-core:RetainedEarningsAccumulatedLosses 2025-12-31 14024267 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14024267 frs-bus:AbridgedAccounts 2025-01-01 2025-12-31 14024267 frs-bus:SmallEntities 2025-01-01 2025-12-31 14024267 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 14024267 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 14024267 frs-bus:Director1 2025-01-01 2025-12-31 14024267 frs-bus:Director2 2025-01-01 2025-12-31 14024267 frs-bus:Director3 2025-01-01 2025-12-31 14024267 frs-bus:Director4 2025-01-01 2025-12-31 14024267 frs-countries:EnglandWales 2025-01-01 2025-12-31 14024267 2023-12-31 14024267 2024-12-31 14024267 2024-01-01 2024-12-31 14024267 frs-core:CurrentFinancialInstruments 2024-12-31 14024267 frs-core:Non-currentFinancialInstruments 2024-12-31 14024267 frs-core:SharePremium 2024-12-31 14024267 frs-core:ShareCapital 2024-12-31 14024267 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31
Registered number: 14024267
Avata Biosciences Holdings Ltd
Unaudited ABRIDGED Financial Statements
For The Year Ended 31 December 2025
Sachdevs
Contents
Page
Balance Sheet 1—2
Notes to the Abridged Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 14024267
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 3,013 2,295
3,013 2,295
CURRENT ASSETS
Debtors 5 1,281,081 1,342,787
Cash at bank and in hand 3,899,533 169,806
5,180,614 1,512,593
Creditors: Amounts Falling Due Within One Year 6 (4,363,054 ) (68,254 )
NET CURRENT ASSETS (LIABILITIES) 817,560 1,444,339
TOTAL ASSETS LESS CURRENT LIABILITIES 820,573 1,446,634
Creditors: Amounts Falling Due After More Than One Year 7 (1,114,750 ) -
NET (LIABILITIES)/ASSETS (294,177 ) 1,446,634
CAPITAL AND RESERVES
Called up share capital 8 167 165
Share premium account 5,121,817 4,736,574
Profit and Loss Account (5,416,161 ) (3,290,105 )
SHAREHOLDERS' FUNDS (294,177) 1,446,634
Page 1
Page 2
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Profit and Loss Account for the year end 31 December 2025 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Dr Andrew Saich
Director
04/06/2026
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Abridged Financial Statements
1. General Information
Avata Biosciences Holdings Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14024267 . The registered office is 6 Stratton Street, Mayfair, London, W1J 8LD.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 20% Reducing Balance
2.3. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Current tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
2.5. Research and development
Expenditure on research and development is written off in the year in which it is incurred.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2024: 4)
3 4
4. Tangible Assets
Computer Equipment
£
Cost
As at 1 January 2025 2,374
Additions 1,342
As at 31 December 2025 3,716
Depreciation
As at 1 January 2025 79
Provided during the period 624
As at 31 December 2025 703
...CONTINUED
Page 3
Page 4
Net Book Value
As at 31 December 2025 3,013
As at 1 January 2025 2,295
5. Debtors
2025 2024
£ £
Due within one year
Other debtors 21,362 90,698
Due after more than one year
Amounts owed by participating interests 1,259,719 1,252,089
1,281,081 1,342,787
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 47,427 38,897
Other creditors 4,253,451 -
Taxation and social security 62,176 29,357
4,363,054 68,254
7. Creditors: Amounts Falling Due After More Than One Year
2025 2024
£ £
Other loans 1,114,750 -
8. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 167 165
Page 4